HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY
ischaemia-reperfusion injury
The findings suggest a potential beneficial effect of tocilizumab on ischaemia-reperfusion injury in STEMI patients and may provide valuable data for further research efforts aimed at improving clinical outcomes and guiding the development of targeted therapies for STEMI patients.